These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 9811498
1. Effect of mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibody. Costantino HR, Andya JD, Nguyen PA, Dasovich N, Sweeney TD, Shire SJ, Hsu CC, Maa YF. J Pharm Sci; 1998 Nov; 87(11):1406-11. PubMed ID: 9811498 [Abstract] [Full Text] [Related]
2. The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody. Andya JD, Maa YF, Costantino HR, Nguyen PA, Dasovich N, Sweeney TD, Hsu CC, Shire SJ. Pharm Res; 1999 Mar; 16(3):350-8. PubMed ID: 10213364 [Abstract] [Full Text] [Related]
3. Understanding the impact of mannitol on physical stability and aerosolization of spray-dried protein powders for inhalation. Arte KS, Tower CW, Mutukuri TT, Chen Y, Patel SM, Munson EJ, Tony Zhou Q. Int J Pharm; 2024 Jan 25; 650():123698. PubMed ID: 38081559 [Abstract] [Full Text] [Related]
4. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation. Shetty N, Park H, Zemlyanov D, Mangal S, Bhujbal S, Zhou QT. Int J Pharm; 2018 Jun 10; 544(1):222-234. PubMed ID: 29678544 [Abstract] [Full Text] [Related]
5. Impact of excipient choice on the aerodynamic performance of inhalable spray-freeze-dried powders. Wanning S, Süverkrüp R, Lamprecht A. Int J Pharm; 2020 Aug 30; 586():119564. PubMed ID: 32590097 [Abstract] [Full Text] [Related]
6. Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations. Hassan A, Farkas D, Longest W, Hindle M. Int J Pharm; 2020 Dec 15; 591():120027. PubMed ID: 33130220 [Abstract] [Full Text] [Related]
7. Understanding the Impact of Protein-Excipient Interactions on Physical Stability of Spray-Dried Protein Solids. Chen Y, Ling J, Li M, Su Y, Arte KS, Mutukuri TT, Taylor LS, Munson EJ, Topp EM, Zhou QT. Mol Pharm; 2021 Jul 05; 18(7):2657-2668. PubMed ID: 34096731 [Abstract] [Full Text] [Related]
8. Protein inhalation powders: spray drying vs spray freeze drying. Maa YF, Nguyen PA, Sweeney T, Shire SJ, Hsu CC. Pharm Res; 1999 Feb 05; 16(2):249-54. PubMed ID: 10100310 [Abstract] [Full Text] [Related]
9. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations. Schüle S, Friess W, Bechtold-Peters K, Garidel P. Eur J Pharm Biopharm; 2007 Jan 05; 65(1):1-9. PubMed ID: 17034996 [Abstract] [Full Text] [Related]
10. Stabilization of IgG1 in spray-dried powders for inhalation. Schüle S, Schulz-Fademrecht T, Garidel P, Bechtold-Peters K, Frieb W. Eur J Pharm Biopharm; 2008 Aug 05; 69(3):793-807. PubMed ID: 18477504 [Abstract] [Full Text] [Related]
11. Physical stability of salmon calcitonin spray-dried powders for inhalation. Chan HK, Clark AR, Feeley JC, Kuo MC, Lehrman SR, Pikal-Cleland K, Miller DP, Vehring R, Lechuga-Ballesteros D. J Pharm Sci; 2004 Mar 05; 93(3):792-804. PubMed ID: 14762916 [Abstract] [Full Text] [Related]
12. Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers. Naini V, Byron PR, Phillips EM. Drug Dev Ind Pharm; 1998 Oct 05; 24(10):895-909. PubMed ID: 9876544 [Abstract] [Full Text] [Related]
13. Particle size dependence of polymorphism in spray-dried mannitol. Lee YY, Wu JX, Yang M, Young PM, van den Berg F, Rantanen J. Eur J Pharm Sci; 2011 Sep 18; 44(1-2):41-8. PubMed ID: 21699976 [Abstract] [Full Text] [Related]
14. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders. Yu J, Chan HK, Gengenbach T, Denman JA. Eur J Pharm Biopharm; 2017 Oct 18; 119():224-234. PubMed ID: 28655664 [Abstract] [Full Text] [Related]
15. Influence of protein on mannitol polymorphic form produced during co-spray drying. Hulse WL, Forbes RT, Bonner MC, Getrost M. Int J Pharm; 2009 Dec 01; 382(1-2):67-72. PubMed ID: 19682563 [Abstract] [Full Text] [Related]
16. Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders. Maa YF, Nguyen PA, Andya JD, Dasovich N, Sweeney TD, Shire SJ, Hsu CC. Pharm Res; 1998 May 01; 15(5):768-75. PubMed ID: 9619788 [Abstract] [Full Text] [Related]
17. Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis. Kwok PC, Grabarek A, Chow MY, Lan Y, Li JC, Casettari L, Mason AJ, Lam JK. Int J Pharm; 2015 Aug 01; 491(1-2):367-74. PubMed ID: 26151107 [Abstract] [Full Text] [Related]
18. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders. Yu J, Romeo MC, Cavallaro AA, Chan HK. Int J Pharm; 2018 Apr 25; 541(1-2):11-18. PubMed ID: 29454904 [Abstract] [Full Text] [Related]
19. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles. Keil TWM, Feldmann DP, Costabile G, Zhong Q, da Rocha S, Merkel OM. Eur J Pharm Biopharm; 2019 Oct 25; 143():61-69. PubMed ID: 31445157 [Abstract] [Full Text] [Related]
20. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers. Li X, Vogt FG, Hayes D, Mansour HM. J Pharm Sci; 2014 Sep 25; 103(9):2937-2949. PubMed ID: 24740732 [Abstract] [Full Text] [Related] Page: [Next] [New Search]